178 results on '"Cancer chemotherapy"'
Search Results
2. Translational PK-PD/TD modeling of antitumor effects and peripheral neuropathy in gemcitabine and nab-paclitaxel chemotherapy from xenograft mice to patients for optimal dose and schedule
3. miRNAs as short non-coding RNAs in regulating doxorubicin resistance
4. Lineage of drug discovery research on fluorinated pyrimidines: chronicle of the achievements accomplished by Professor Setsuro Fujii
5. Systemic exposure to cisplatin and paclitaxel after intraperitoneal chemotherapy in ovarian cancer
6. A redox-responsive delivery system for paclitaxel based on heparin—pluronic F127 nanogel
7. Association of frailty with chemotherapy toxicity in chemotherapy-naive older patients with cancer
8. New Advances in Supportive Care: Chemoprotective Agents as Novel Opportunities in Geriatric Oncology
9. A Tumor Homing Peptide-Conjugated Poly(epsilon-lysine) Delivery System for Improved Antitumor Drug Loading and Targeting
10. Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity
11. Hormesis: A Fundamental Concept in Biology
12. Cardiotoxicity linked to anticancer agents and cardioprotective strategy
13. Adagrasib, a KRAS G12C inhibitor, reverses the multidrug resistance mediated by ABCB1 in vitro and in vivo
14. Current and emerging mass spectrometry methods for the preclinical development of metal-based drugs: a critical appraisal
15. Optimum multi-drug regime for compartment model of tumour: cell-cycle-specific dynamics in the presence of resistance
16. Moderating effect of sense of coherence on the relationship between symptom distress and health-related quality of life in patients receiving cancer chemotherapy
17. Coumarin derivative 7-isopentenyloxycoumarin induces in vivo antitumor activity by inhibit angiogenesis via CCL2 chemokine decrease
18. Fighting cancer with microtubule-stabilizing agents: a computational investigation of the complex between β-tubulin and the microtubule-stabilizing, antitumor marine diterpenoid sarcodictyin A
19. Designing a drug delivery system for improved tumor treatment and targeting by functionalization of a cell-penetrating peptide
20. The impact of the oral cavity in febrile neutropenia and infectious complications in patients treated with myelosuppressive chemotherapy
21. Development of a Lyophilized Formulation of Pegaspargase and Comparability Versus Liquid Pegaspargase
22. Selective inhibition of P-gp transporter by goniothalamin derivatives sensitizes resistant cancer cells to chemotherapy
23. Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study
24. Chemotherapy use and quality of life in cancer patients at the end of life: an integrative review
25. A dual stimuli-responsive star-shaped nanocarrier as de novo drug delivery system for chemotherapy of solid tumors
26. Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice
27. Different ODE models of tumor growth can deliver similar results
28. Multiday corticosteroids in cancer chemotherapy delay the diagnosis of and antimicrobial administration for febrile neutropenia: a double-center retrospective study
29. Cardiotoxicity in Hematological Diseases: Are the Tyrosine Kinase Inhibitors Imatinib and Nilotinib Safe?
30. Instability of the Null Steady State: The Fundamental Problem of Inhibiting Malignant Cell Growth
31. Large Group Case-Based Learning (TB-CBL) Is an Effective Method for Teaching Cancer Chemotherapy to Medical Students
32. Totally implantable venous access ports: a prospective long-term study of early and late complications in adult patients with cancer
33. Dual drug-loaded PLA nanoparticles bypassing drug resistance for improved leukemia therapy
34. Practice Patterns in Hepatitis B Virus Screening Before Cancer Chemotherapy in a Major US Hospital Network
35. Regulation of paclitaxel activity by microtubule-associated proteins in cancer chemotherapy
36. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
37. Identification of adverse events that have a negative impact on quality of life in a clinical trial comparing docetaxel versus S-1 with cisplatin in lung cancer
38. Effects of a bolus injection of 5-fluorouracil on dihydropyrimidine dehydrogenase activity in rats receiving continuous infusion of 5-fluorouracil
39. Structural basis of DNA topoisomerase II-α (Top2-α) inhibition: a computational analysis of interactions between Top2-α and its inhibitors
40. Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues
41. Drug fever after cancer chemotherapy is most commonly observed on posttreatment days 3 and 4
42. Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary
43. Validated method for occupational cyclophosphamide monitoring using LC-MS/MS and a Poroshell 120 column
44. Differential nucleobase protection against 5-fluorouracil toxicity for squamous and columnar cells: implication for tissue function and oncogenesis
45. Overcoming ABCG2-mediated drug resistance with imidazo-[1,2-b]-pyridazine-based Pim1 kinase inhibitors
46. Testing the effectiveness of antiemetic guidelines: results of a prospective registry by the CINV Study Group of Japan
47. Diagnosis, Management, and Prevention of Hepatitis B Reactivation
48. Is the eGFR formula adequate for evaluating renal function before chemotherapy in patients with urogenital cancer? A suggestion for clinical application of eGFR formula
49. Multidrug Resistance Proteins (MRPs) and Cancer Therapy
50. Thiol-mediated multiple mechanisms centered on selenodiglutathione determine selenium cytotoxicity against MCF-7 cancer cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.